Variant report
Variant | nsv964925 |
---|---|
Chromosome Location | chr5:113171691-113185521 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs189835518 | chr5:113180400-113180401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79948181 | chr5:113180414-113180415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs114201039 | chr5:113180508-113180509 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558903793 | chr5:113180528-113180529 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574133297 | chr5:113180530-113180531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs561265465 | chr5:113180539-113180540 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145247408 | chr5:113180555-113180556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs1351608 | chr5:113180637-113180638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs1351607 | chr5:113180653-113180654 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs530348862 | chr5:113180695-113180696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550064809 | chr5:113180785-113180786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542096374 | chr5:113180827-113180828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374390742 | chr5:113180830-113180831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73243066 | chr5:113180852-113180853 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs532851740 | chr5:113180869-113180870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs137869152 | chr5:113180912-113180913 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs563332930 | chr5:113180917-113180918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566391478 | chr5:113180927-113180928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs536621344 | chr5:113180929-113180930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548607298 | chr5:113180966-113180967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs570013876 | chr5:113180968-113180969 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs181293216 | chr5:113180994-113180995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530418378 | chr5:113181017-113181018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs13174900 | chr5:113181034-113181035 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs534591961 | chr5:113181060-113181061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs184285077 | chr5:113181083-113181084 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs574410706 | chr5:113181102-113181103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs541375937 | chr5:113181206-113181207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563302508 | chr5:113181260-113181261 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs530103190 | chr5:113181281-113181282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs4299731 | chr5:113181289-113181290 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs528157326 | chr5:113181315-113181316 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs144659413 | chr5:113181320-113181321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111464541 | chr5:113181328-113181329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs540271646 | chr5:113181390-113181391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs900306 | chr5:113181396-113181397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs568236998 | chr5:113181468-113181469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs75757604 | chr5:113181482-113181483 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs560042463 | chr5:113181519-113181520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs900305 | chr5:113181521-113181522 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs372158607 | chr5:113181567-113181568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530427289 | chr5:113181598-113181599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs112432652 | chr5:113181617-113181618 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs556966013 | chr5:113181642-113181643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs548282984 | chr5:113181646-113181647 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377236000 | chr5:113181710-113181711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs570078548 | chr5:113181729-113181730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs567753711 | chr5:113181760-113181761 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149788243 | chr5:113181761-113181762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570080880 | chr5:113181778-113181779 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Autism | 22495309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:113180400-113181000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
2 | chr5:113180600-113181000 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr5:113180600-113181000 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr5:113181000-113182400 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
5 | chr5:113181000-113182400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr5:113182200-113183600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
7 | chr5:113182400-113182600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr5:113182400-113183800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
9 | chr5:113182800-113183200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
10 | chr5:113182800-113183600 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr5:113182800-113183600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
12 | chr5:113182800-113183800 | Enhancers | ES-WA7 Cell Line | embryonic stem cell |
13 | chr5:113182800-113183800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
14 | chr5:113183000-113183400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr5:113183000-113183400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr5:113183400-113183800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |